Responsible for leading the west region team of Reimbursement Specialists.

Within the Market Access & Pricing marketing group, responsible for strategy and execution of policies for patients with governments payers (Medicare, Medicaid, VA/DoD).Responsible for US market access payer preparation for an investigational drug for lupus.Lead strategy for ICD-10 implementation for MAP team.

Responsible for field reimbursement services for Missouri, Arkansas and Oklahoma - revenue cycle management and healthcare finance management for private accounts and institutional customers who prescribe Cimzia under the medical benefit (buy and bill model).Responsible for interface with local Medicare jurisdictions when changes to health policy arise for UCB's portfolio drugs.President's Club winner 2014

Promoted to position of Channel Access Executive, responsible for contracting with targeted accounts within region to purchase Cimzia lyophilized formulation from partner distributors.President's Club winner - 2012 Provide extensive reimbursement services for targeted accounts, and assistance to sales teams to develop their reimbursement knowledge. Work with National Accounts Manager in order to facilitate favorable status on plans with payors that affect this region. Implementing a hospital-based access program for Cimzia lyo through GPOs. Geography - Missouri, Arkansas, Oklahoma

Recruited to launch Orencia, an infusion for rheumatoid arthritis, and manage St. Louis metropolitan territory as well as 50% of Missouri state.

Core Responsibilities - Recruited to promote Amevive, an injection for chronic plaque psoriasis.

Core Responsibilities - Recruited to launch Kineret, a biologic injection for rheumatoid arthritis within newly formed Immunoscience Business Unit. Later, focus shifted to promote Enbrel following company's acquisition of Immunex. Served as District Trainer within high turnover business unit; trained new-hires on disease state, competition, and products and services. Served as interim District Sales Manager during the loss of consecutive DSMs.

Sales responsibilities for anesthesia and psychiatry.